BDBM795227 N-(cyanomethyl)-4-(2-(4-(4-hydroxypiperidin-1-yl)phenylamino)-5-methylpyrimidin-4-yl)benzamide::US12570614, Compound 58

SMILES Cc1cnc(Nc2ccc(N3CCC(O)CC3)cc2)nc1-c1ccc(C(=O)NCC#N)cc1

InChI Key

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 2 hits for monomerid = 795227   

TargetTyrosine-protein kinase JAK3(Human)
Glaxosmith Kline

US Patent
LigandChemical structure of BindingDB Monomer ID 795227BDBM795227(N-(cyanomethyl)-4-(2-(4-(4-hydroxypiperidin-1-yl)p...)
Affinity DataIC50: 1.00E+3nMAssay Description:The cell-based assays is based on IL-6 ELISA quantification. Briefly, A549 cells are cultured in DMEM with 10% FBS medium. When cells reach 80% confl...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
7/20/2026
Entry Details US Patent

TargetTyrosine-protein kinase JAK2(Human)
Glaxosmith Kline

US Patent
LigandChemical structure of BindingDB Monomer ID 795227BDBM795227(N-(cyanomethyl)-4-(2-(4-(4-hydroxypiperidin-1-yl)p...)
Affinity DataIC50: 1.00E+3nMAssay Description:The cell-based assays is based on IL-6 ELISA quantification. Briefly, A549 cells are cultured in DMEM with 10% FBS medium. When cells reach 80% confl...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
7/20/2026
Entry Details US Patent